Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
Topics Covered
- What is Hypertrophic Cardiomyopathy?
- Natural history of the disease
- Current surgical and non-surgical treatments
- Novel treatments
Biography
Srihari S. Naidu is a Professor of Medicine at New York Medical College, Valhalla, NY. He graduated from Brown University in Providence, Rhode Island for both undergraduate and medical school as part of the 8-year program. Following this, he was a resident at New York Presbyterian Hospital – Cornell Medical Center in Manhattan, and then a cardiology and interventional cardiology fellow at the University of Pennsylvania in Philadelphia, Pennsylvania. After several years as an attending at New York Presbyterian – Cornell and NYU Winthrop, he moved to Westchester Medical Center and New York Medical College. There he is currently Director of the Cardiac Catheterization Laboratories and Hypertrophic Cardiomyopathy National Center of Excellence - with offices in Long Island and Westchester - at Westchester Medical Center in Valhalla, NY. He is a two-term Past Member of the American College of Cardiology (ACC) Interventional Scientific Council, Associate Director of Transcatheter Cardiovascular Therapeutics (TCT), and has served on the Program Committee for the American Heart Association Annual Scientific Sessions.
He is the author of over 130 original scientific manuscripts, and has authored clinical practice guidelines and consensus statements on behalf of the American College of Cardiology (ACC), American Heart Association (AHA) and the Society for Cardiovascular Angiography and Interventions (SCAI), including Chairing the National Best Practices in the Cardiac Catheterization Laboratory document that outlines optimal process improvement for all cardiac catheterization laboratories in the United States. Naidu is Founder and Past Chair of the Emerging Leader Mentorship (ELM) Program for SCAI (in partnership with ACC and the Cardiovascular Research Foundation), a national leadership pipeline initiated in 2010 that identifies and trains 12 interventional cardiologists every two years.
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Naidu, S. (2020, November 10). Hypertrophic cardiomyopathy: therapies and treatments [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/URTO3606.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Srihari Naidu has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.